LifeMD Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $4.64
- Today's High:
- $5.0397
- Open Price:
- $4.64
- 52W Low:
- $1.14
- 52W High:
- $5.45
- Prev. Close:
- $4.69
- Volume:
- 554929
Company Statistics
- Market Cap.:
- $157.64 million
- Book Value:
- -0.494
- Revenue TTM:
- $128.61 million
- Operating Margin TTM:
- -16.66%
- Gross Profit TTM:
- $100.37 million
- Profit Margin:
- -23.3%
- Return on Assets TTM:
- -36.48%
- Return on Equity TTM:
- -782.48%
Company Profile
LifeMD Inc had its IPO on 2001-01-02 under the ticker symbol LFMD.
The company operates in the Healthcare sector and Health Information Services industry. LifeMD Inc has a staff strength of 199 employees.
Stock update
Shares of LifeMD Inc opened at $4.64 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $4.64 - $5.04, and closed at $4.72.
This is a +0.64% increase from the previous day's closing price.
A total volume of 554,929 shares were traded at the close of the day’s session.
In the last one week, shares of LifeMD Inc have increased by +11.06%.
LifeMD Inc's Key Ratios
LifeMD Inc has a market cap of $157.64 million, indicating a price to book ratio of 22.574 and a price to sales ratio of 0.6113.
In the last 12-months LifeMD Inc’s revenue was $128.61 million with a gross profit of $100.37 million and an EBITDA of $-20173546. The EBITDA ratio measures LifeMD Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, LifeMD Inc’s operating margin was -16.66% while its return on assets stood at -36.48% with a return of equity of -782.48%.
In Q2, LifeMD Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 18%.
LifeMD Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-1.1 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into LifeMD Inc’s profitability.
LifeMD Inc stock is trading at a EV to sales ratio of 0.6593 and a EV to EBITDA ratio of -1.7737. Its price to sales ratio in the trailing 12-months stood at 0.6113.
LifeMD Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $35.45 million
- Total Liabilities
- $31.52 million
- Operating Cash Flow
- $-2301300.00
- Capital Expenditure
- $2.30 million
- Dividend Payout Ratio
- 0%
LifeMD Inc ended 2024 with $35.45 million in total assets and $0 in total liabilities. Its intangible assets were valued at $35.45 million while shareholder equity stood at $-10988628.00.
LifeMD Inc ended 2024 with $0 in deferred long-term liabilities, $31.52 million in other current liabilities, 325649.00 in common stock, $-202857575.00 in retained earnings and $0 in goodwill. Its cash balance stood at $11.91 million and cash and short-term investments were $11.91 million. The company’s total short-term debt was $1,494,461 while long-term debt stood at $13.54 million.
LifeMD Inc’s total current assets stands at $20.18 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $3.67 million compared to accounts payable of $9.59 million and inventory worth $3.70 million.
In 2024, LifeMD Inc's operating cash flow was $-2301300.00 while its capital expenditure stood at $2.30 million.
Comparatively, LifeMD Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $4.72
- 52-Week High
- $5.45
- 52-Week Low
- $1.14
- Analyst Target Price
- $5.25
LifeMD Inc stock is currently trading at $4.72 per share. It touched a 52-week high of $5.45 and a 52-week low of $5.45. Analysts tracking the stock have a 12-month average target price of $5.25.
Its 50-day moving average was $4.18 and 200-day moving average was $2.58 The short ratio stood at 3.86 indicating a short percent outstanding of 0%.
Around 2345% of the company’s stock are held by insiders while 1700.9% are held by institutions.
Frequently Asked Questions About LifeMD Inc
Similar Industry Stocks (Health Information Services)
Most Active
Top Gainers
Top Losers
About
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including urgent and primary care, men’s and women’s health, and dermatology, chronic care management, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and food and drug administration approved medical device for male and female hair loss; RexMD, a men’s telehealth brand that offers virtual medical treatment from licensed providers for a variety of men’s health needs; LifeMD Primary Care, a virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and NavaMD, a female-oriented and tele-dermatology brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. The company sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.